3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Polycystic Ovary Syndrome
5
Weight Loss
3
Obesity
3
Overweight
2
Obesity, Abdominal
1
Moderately Overweight Individuals
1
Metabolic Syndrome
1
Metabolic Diseases
1
Menstruation Disturbances
1
Intermittent Fasting
1
Insulin Resistance
1
Glucocorticoid Receptor Deficiency
1
Fasting
1
Breast Neoplasms
1
Breast Cancer Female
1
Interventions
Exercise
3
Paclitaxel
2
Cyclophosphamide
2
Control Groups
2
Capecitabine
2
Bupivacaine
2
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
palbociclib
1
iniparib
1
darolutamide
1
Yoga
1
Waiting Lists
1
Vitamin D
1
Thioctic Acid
1
Surveys and Questionnaires
1
Sodium Chloride
1
Ropivacaine
1
Radiofrequency Ablation
1
Neoadjuvant Therapy
1
Methotrexate
1
Metformin
1
Mastectomy, Segmental
1
Mastectomy
1
Letrozole
1
Electrochemotherapy
1
Educational Status
1
Drug Delivery Systems
1
Doxorubicin
1
Diet
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Breast Cancer Female
×
Caloric Restriction
×
Clear all
NCT03131024
2024-09-19
CREATE
University of Alberta
Phase NA
Completed
58 enrolled